680 related articles for article (PubMed ID: 12403637)
1. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
Levy E; Levy P
Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
[TBL] [Abstract][Full Text] [Related]
2. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
3. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
5. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
[TBL] [Abstract][Full Text] [Related]
7. Medical advances in the treatment of congestive heart failure.
Armstrong PW; Moe GW
Circulation; 1993 Dec; 88(6):2941-52. PubMed ID: 7902784
[TBL] [Abstract][Full Text] [Related]
8. [Drug treatment of cardiac insufficiency with systolic dysfunction].
Follath F
Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344
[TBL] [Abstract][Full Text] [Related]
9. Congestive heart failure: what should be the initial therapy and why?
Chatterjee K
Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
[TBL] [Abstract][Full Text] [Related]
10. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
11. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
Teo KK; Ignaszewski AP; Gutierrez R; Hill KL; Martin SL; Calhoun HP; Humen DP; Montague TJ
Can J Cardiol; 1992; 8(6):611-9. PubMed ID: 1354569
[TBL] [Abstract][Full Text] [Related]
12. Community management of heart failure.
McKelvie RS
Can Fam Physician; 1998 Dec; 44():2689-92, 2695-8. PubMed ID: 9870122
[TBL] [Abstract][Full Text] [Related]
13. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
Hilleman DE
Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
[TBL] [Abstract][Full Text] [Related]
14. Clinical treatment regimens for chronic heart failure: a review.
Gould PA; Kaye DM
Expert Opin Pharmacother; 2002 Nov; 3(11):1569-76. PubMed ID: 12437491
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
[TBL] [Abstract][Full Text] [Related]
16. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
17. Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature.
Litaker JR; Chou JY
Clin Ther; 2003 Jul; 25(7):1918-35. PubMed ID: 12946542
[TBL] [Abstract][Full Text] [Related]
18. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of cardiac insufficiency: status 1995].
Rickenbacher P; Buser P; Osswald S; Pfisterer M
Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacologic treatment of chronic congestive heart failure].
Halawa B
Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
